HHS Overrides FDA Review Decision, Blocks Teva’s OTC Plan B Application

Drug Industry Daily
A A
HHS Secretary Kathleen Sebelius has directed the FDA to issue a complete response letter for Teva’s bid to make Plan B birth control OTC, despite a favorable review by CDER.

To View This Article:

Login

Subscribe To Drug Industry Daily